
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>The Soluble Specific Substance of Pneumococcus: Third Paper</dc:title>
  <dc:subject>Streptococcus pneumoniae</dc:subject>
  <dc:subject>Pneumococcal Infections</dc:subject>
  <dc:description>In this important article, Avery and Heidelberger continued their work on identifying the substance that caused each type of pneumococcus to elicit a unique immune response.  Here, they determined that Type I and Type II pneumococcus strains contained chemically distinct polysaccharides, thus indicating that these unique polysaccharides were in fact the antigenic substance that determined the different levels of virulence among types of pneumococcus.</dc:description>
  <dc:publisher>Rockefeller Institute for Medical Research, October 1925</dc:publisher>
  <dc:publisher>Rockefeller Institute for Medical Research, October 1925</dc:publisher>
  <dc:contributor>Journal of Experimental Medicine</dc:contributor>
  <dc:contributor></dc:contributor>
  <dc:contributor>Heidelberger, Michael</dc:contributor>
  <dc:contributor></dc:contributor>
  <dc:contributor>Goebel, Walther F.</dc:contributor>
  <dc:contributor></dc:contributor>
  <dc:contributor>Avery, Oswald T.</dc:contributor>
  <dc:contributor></dc:contributor>
  <dc:type>Articles</dc:type>
  <dc:format>Archival Materials</dc:format>
  <dc:format>Text</dc:format>
  <dc:format>19 pages</dc:format>
  <dc:identifier>nlm:nlmuid-101584940X5-doc</dc:identifier>
  <dc:identifier>101584940X5</dc:identifier>
  <dc:identifier>http://resource.nlm.nih.gov/101584940X5</dc:identifier>
  <dc:identifier>Profiles ID: DHBBBG</dc:identifier>
  <dc:language>English</dc:language>
  <dc:relation>Profiles in Science</dc:relation>
</oai_dc:dc>